These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 27891816)
1. DLL4 overexpression increases gastric cancer stem/progenitor cell self-renewal ability and correlates with poor clinical outcome via Notch-1 signaling pathway activation. Miao ZF; Xu H; Xu HM; Wang ZN; Zhao TT; Song YX; Xu YY Cancer Med; 2017 Jan; 6(1):245-257. PubMed ID: 27891816 [TBL] [Abstract][Full Text] [Related]
2. Combination DLL4 with Jagged1-siRNA can enhance inhibition of the proliferation and invasiveness activity of human gastric carcinoma by Notch1/VEGF pathway. Sun HW; Wu C; Tan HY; Wang QS Hepatogastroenterology; 2012 May; 59(115):924-9. PubMed ID: 22020917 [TBL] [Abstract][Full Text] [Related]
3. Influence of up-regulation of Notch ligand DLL4 on biological behaviors of human gastric cancer cells. Li GG; Li L; Li C; Ye LY; Li XW; Liu DR; Bao Q; Zheng YX; Xiang DP; Chen L; Chen J World J Gastroenterol; 2013 Jul; 19(28):4486-94. PubMed ID: 23901223 [TBL] [Abstract][Full Text] [Related]
4. Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme. El Hindy N; Keyvani K; Pagenstecher A; Dammann P; Sandalcioglu IE; Sure U; Zhu Y Neuro Oncol; 2013 Oct; 15(10):1366-78. PubMed ID: 23787764 [TBL] [Abstract][Full Text] [Related]
5. Peritoneal milky spots serve as a hypoxic niche and favor gastric cancer stem/progenitor cell peritoneal dissemination through hypoxia-inducible factor 1α. Miao ZF; Wang ZN; Zhao TT; Xu YY; Gao J; Miao F; Xu HM Stem Cells; 2014 Dec; 32(12):3062-74. PubMed ID: 25142304 [TBL] [Abstract][Full Text] [Related]
6. FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4. McClements L; Annett S; Yakkundi A; O'Rourke M; Valentine A; Moustafa N; Alqudah A; Simões BM; Furlong F; Short A; McIntosh SA; McCarthy HO; Clarke RB; Robson T BMC Cancer; 2019 Apr; 19(1):351. PubMed ID: 30975104 [TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer. Kim DH; Lee S; Kang HG; Park HW; Lee HW; Kim D; Yoem DH; Ahn JH; Ha E; You WK; Lee SH; Kim SJ; Chun KH BMB Rep; 2020 Nov; 53(10):533-538. PubMed ID: 32580836 [TBL] [Abstract][Full Text] [Related]
8. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma. Xiao W; Gao Z; Duan Y; Yuan W; Ke Y J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221 [TBL] [Abstract][Full Text] [Related]
9. Role of Notch signaling pathway in gastric cancer: a meta-analysis of the literature. Du X; Cheng Z; Wang YH; Guo ZH; Zhang SQ; Hu JK; Zhou ZG World J Gastroenterol; 2014 Jul; 20(27):9191-9. PubMed ID: 25083094 [TBL] [Abstract][Full Text] [Related]
10. Dll4/Notch1 signalling pathway is required in collective invasion of salivary adenoid cystic carcinoma. Wang K; Fan HY; Pang X; Zhang M; Yu XH; Wu JS; Chen BJ; Jiang J; Liang XH; Tang YL Oncol Rep; 2021 Mar; 45(3):1011-1022. PubMed ID: 33469672 [TBL] [Abstract][Full Text] [Related]
11. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma. Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580 [TBL] [Abstract][Full Text] [Related]
12. Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth. Ding XY; Ding J; Wu K; Wen W; Liu C; Yan HX; Chen C; Wang S; Tang H; Gao CK; Guo LN; Cao D; Li Z; Feng GS; Wang HY; Xu ZF Oncogene; 2012 Jun; 31(23):2899-906. PubMed ID: 22002304 [TBL] [Abstract][Full Text] [Related]
13. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer. Cai C; Zhu X Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735 [TBL] [Abstract][Full Text] [Related]
15. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4. Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985 [TBL] [Abstract][Full Text] [Related]
16. Mammalian Numb protein antagonizes Notch by controlling postendocytic trafficking of the Notch ligand Delta-like 4. Shao X; Ding Z; Zhao M; Liu K; Sun H; Chen J; Liu X; Zhang Y; Hong Y; Li H; Li H J Biol Chem; 2017 Dec; 292(50):20628-20643. PubMed ID: 29042443 [TBL] [Abstract][Full Text] [Related]
17. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway. Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685 [TBL] [Abstract][Full Text] [Related]
18. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway. Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744 [TBL] [Abstract][Full Text] [Related]
19. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291 [TBL] [Abstract][Full Text] [Related]
20. MMGZ01, an anti-DLL4 monoclonal antibody, promotes nonfunctional vessels and inhibits breast tumor growth. Xu Z; Wang Z; Jia X; Wang L; Chen Z; Wang S; Wang M; Zhang J; Wu M Cancer Lett; 2016 Mar; 372(1):118-27. PubMed ID: 26739060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]